Radiation therapy planning software developer RaySearch Laboratories has received U.S. Food and Drug Administration (FDA) 510(k) clearance for version 4.5 of its RayStation software.
Version 4.5 includes faster optimization for proton and photon treatments, as well as enhanced dose calculation capabilities, according to the vendor. In addition, RaySearch said it has added automated breast planning and biomechanical deformable registration tools via the Morfeus technology, which it has licensed from Princess Margaret Hospital in Toronto.
RayStation's rayOptimizer optimization engine has been upgraded to account for density and patient setup uncertainties. In addition to including completely rewritten dose calculation algorithms, the new version of RayStation supports the use of a graphics processing unit (GPU) to provide optimization and dose computation, RaySearch said.
A new rayAutoBreast module includes tools to provide automated generation of tangential breast intensity-modulated radiation therapy (IMRT) plans using heuristic optimization, RaySearch said.
